METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma

Citation:

Xiangyu Zeng, Fei Zhao, Gaofeng Cui, Yong Zhang, Rajashree A Deshpande, Yuping Chen, Min Deng, Jake A Kloeber, Yu Shi, Qin Zhou, Chao Zhang, Jing Hou, Wootae Kim, Xinyi Tu, Yuanliang Yan, Zhijie Xu, Lifeng Chen, Huanyao Gao, Guijie Guo, Jiaqi Liu, Qian Zhu, Yueyu Cao, Jinzhou Huang, Zheming Wu, Shouhai Zhu, Ping Yin, Kuntian Luo, Georges Mer, Tanya T Paull, Jian Yuan, Kaixiong Tao, and Zhenkun Lou. “METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.” Nat Cancer, 3, 9, Pp. 1088-1104.